SEMA4D and diabetes mellitus: Sema4d−/− mice show attenuated pathological retinal neovascularization and vascular leakage in a streptozotocin-induced diabetes or oxygen-induced retinopathy model, indicating the pathological roles of Sema4D signaling in retinopathy.